Emily Menendez

Emily Menendez is an assistant editor for GU Oncology Now and Cancer Nursing Today. She uses her copywriting experience to contribute content on the latest updates in the oncology nursing sphere. Ms. Menendez received her BA from the University of Central Florida.

Articles by Emily Menendez

Emily MenendezmCRPC | February 1, 2023
A study compared the gross and OOP payments for 6 different first-line mCRPC drugs during the 6 months post-treatment start.
Read More
Emily MenendezNon-Muscle Invasive Urothelial Carcinoma | January 25, 2023
Researchers developed a randomized phase II clinical trial for patients with NMIBC before transurethral resection of tumors.
Emily MenendezAdvanced Renal Cell Carcinoma | January 25, 2023
Researchers performed a cost-effectiveness analysis of sunitinib and 6 immunotherapy-TKI/immunotherapy drug combinations.
Emily MenendezLocalized Prostate Cancer | January 23, 2023
A recent update on the phase 3 MIRAGE trial determined if MRI or CT-guided stereotactic body radiotherapy is most effective.
Emily MenendezMuscle Invasive Urothelial Carcinoma | January 23, 2023
Researchers examined the impact of care fragmentation on patients receiving neoadjuvant chemotherapy and radical cystectomy.
Emily MenendezProstate Cancer | January 23, 2023
Prostate cancer drug abiraterone acetate has recently been developed in an oral suspension form as an alternative to tablets.
Shyam Natarajan, PhDExpert Interviews | January 20, 2023
GU Oncology Now spoke with Shyam Natarajan to discuss Avenda's iQuest and how AI can be used in the field of cancer care.
Emily MenendezProstate Cancer | January 13, 2023
Our industry insights compile monthly news and updates across the GU oncology sphere.
Emily MenendezTesticular, Penile, and Rare Malignancies | January 12, 2023
A study analyzed 228 patients with penile cancer who underwent pelvic lymph node treatment with curative intent.
Emily MenendezRLT-PSMA | January 12, 2023
While PSMA-RLT is typically used during later disease stages, patients in earlier disease stages may benefit as well.